Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivo

[1]  Cora R. von Collenberg,et al.  CDNF rescues motor neurons in three animal models of ALS by targeting ER stress , 2020, bioRxiv.

[2]  H. Lashuel.  Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports , 2020, Neurobiology of Disease.

[3]  Shirin Doroudgar,et al.  Mesencephalic astrocyte–derived neurotrophic factor is an ER-resident chaperone that protects against reductive stress in the heart , 2020, The Journal of Biological Chemistry.

[4]  P. Alam,et al.  α‐synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities , 2019, Journal of neurochemistry.

[5]  M. Saarma,et al.  CDNF Protein Therapy in Parkinson’s Disease , 2019, Cell transplantation.

[6]  M. Saarma,et al.  Characterization of CDNF-Secreting ARPE-19 Cell Clones for Encapsulated Cell Therapy , 2019, Cell transplantation.

[7]  D. Ron,et al.  MANF antagonizes nucleotide exchange by the endoplasmic reticulum chaperone BiP , 2019, Nature Communications.

[8]  P. Zamorano,et al.  CDNF induces the adaptive unfolded protein response and attenuates endoplasmic reticulum stress-induced cell death. , 2018, Biochimica et biophysica acta. Molecular cell research.

[9]  B. Harvey,et al.  KDEL Receptors Are Differentially Regulated to Maintain the ER Proteome under Calcium Deficiency. , 2018, Cell reports.

[10]  Xiao-Jing Wang,et al.  Cerebral Dopamine Neurotrophic Factor (CDNF) Has Neuroprotective Effects against Cerebral Ischemia That May Occur through the Endoplasmic Reticulum Stress Pathway , 2018, International journal of molecular sciences.

[11]  R. Takahashi,et al.  Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve , 2018, Molecular Neurodegeneration.

[12]  Olli-Pekka Smolander,et al.  Poststroke delivery of MANF promotes functional recovery in rats , 2018, Science Advances.

[13]  T. P. Davis,et al.  Serum albumin impedes the amyloid aggregation and hemolysis of human islet amyloid polypeptide and alpha synuclein. , 2018, Biochimica et biophysica acta. Biomembranes.

[14]  K. Khodosevich,et al.  MANF Promotes Differentiation and Migration of Neural Progenitor Cells with Potential Neural Regenerative Effects in Stroke , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  A. West,et al.  α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration , 2017, Neurobiology of Disease.

[16]  Xander M R van Wijk,et al.  Cellular internalization of alpha-synuclein aggregates by cell surface heparan sulfate depends on aggregate conformation and cell type , 2017, Scientific Reports.

[17]  V. Lee,et al.  Selective imaging of internalized proteopathic α-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies , 2017, The Journal of Biological Chemistry.

[18]  H. Braak,et al.  Neuropathological Staging of Brain Pathology in Sporadic Parkinson’s disease: Separating the Wheat from the Chaff , 2017, Journal of Parkinson's disease.

[19]  M. Saarma,et al.  Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of Action , 2017, eNeuro.

[20]  M. Saarma,et al.  Intrastriatally Infused Exogenous CDNF Is Endocytosed and Retrogradely Transported to Substantia Nigra , 2017, eNeuro.

[21]  R. Román,et al.  Enhancing heterologous protein expression and secretion in HEK293 cells by means of combination of CMV promoter and IFNα2 signal peptide. , 2016, Journal of biotechnology.

[22]  T. Outeiro,et al.  Structure, function and toxicity of alpha‐synuclein: the Bermuda triangle in synucleinopathies , 2016, Journal of neurochemistry.

[23]  Ho Chul Kang,et al.  Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3 , 2016, Science.

[24]  John Q Trojanowski,et al.  Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s disease , 2016, The Journal of experimental medicine.

[25]  H. Jasper,et al.  Immune modulation by MANF promotes tissue repair and regenerative success in the retina , 2016, Science.

[26]  Elliott W. Dirr,et al.  Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration , 2015, Neurobiology of Disease.

[27]  Takeo Kato,et al.  Sensitive western blotting for detection of endogenous Ser129-phosphorylated α-synuclein in intracellular and extracellular spaces , 2015, Scientific Reports.

[28]  M. Almeida,et al.  The Solution Structure and Dynamics of Full-length Human Cerebral Dopamine Neurotrophic Factor and Its Neuroprotective Role against α-Synuclein Oligomers* , 2015, The Journal of Biological Chemistry.

[29]  C. Meyers,et al.  The loss of glucose-regulated protein 78 (GRP78) during normal aging or from siRNA knockdown augments human alpha-synuclein (α-syn) toxicity to rat nigral neurons , 2015, Neurobiology of Aging.

[30]  Vivek K Unni,et al.  Progressive aggregation of alpha-synuclein and selective degeneration of Lewy inclusion-bearing neurons in a mouse model of parkinsonism , 2015, Cell reports.

[31]  H. Huttunen,et al.  Prolyl Oligopeptidase Enhances α-Synuclein Dimerization via Direct Protein-Protein Interaction* , 2015, The Journal of Biological Chemistry.

[32]  G. Braus,et al.  Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation , 2014, PLoS genetics.

[33]  K. Luk,et al.  Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite–like aggregates , 2014, Nature Protocols.

[34]  C. Hetz,et al.  Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1 , 2014, Proceedings of the National Academy of Sciences.

[35]  L. Lannfelt,et al.  Monoclonal antibodies selective for α‐synuclein oligomers/protofibrils recognize brain pathology in Lewy body disorders and α‐synuclein transgenic mice with the disease‐causing A30P mutation , 2013, Journal of neurochemistry.

[36]  E. Masliah,et al.  A Blood-Brain Barrier (BBB) Disrupter Is Also a Potent α-Synuclein (α-syn) Aggregation Inhibitor , 2013, The Journal of Biological Chemistry.

[37]  J. Trojanowski,et al.  Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice , 2012, Science.

[38]  Ronald Melki,et al.  Neuron‐to‐neuron transmission of α‐synuclein fibrils through axonal transport , 2012, Annals of neurology.

[39]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[40]  J. Trojanowski,et al.  Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice , 2012, The Journal of experimental medicine.

[41]  J. Troncoso,et al.  Accumulation of Toxic α-Synuclein Oligomer within Endoplasmic Reticulum Occurs in α-Synucleinopathy In Vivo , 2012, The Journal of Neuroscience.

[42]  P. Spano,et al.  Redistribution of DAT/α-Synuclein Complexes Visualized by “In Situ” Proximity Ligation Assay in Transgenic Mice Modelling Early Parkinson's Disease , 2011, PloS one.

[43]  C. Rivera,et al.  Neurturin Evokes MAPK-Dependent Upregulation of Egr4 and KCC2 in Developing Neurons , 2011, Neural plasticity.

[44]  Fred H. Gage,et al.  In vivo demonstration that α-synuclein oligomers are toxic , 2011, Proceedings of the National Academy of Sciences.

[45]  Brian Spencer,et al.  Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein , 2009, Proceedings of the National Academy of Sciences.

[46]  Polina Golland,et al.  Scoring diverse cellular morphologies in image-based screens with iterative feedback and machine learning , 2009, Proceedings of the National Academy of Sciences.

[47]  Polina Golland,et al.  CellProfiler Analyst: data exploration and analysis software for complex image-based screens , 2008, BMC Bioinformatics.

[48]  R. Hauser,et al.  Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease , 2008, Nature Medicine.

[49]  Elisabet Englund,et al.  Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation , 2008, Nature Medicine.

[50]  Armin Giese,et al.  Different Species of α-Synuclein Oligomers Induce Calcium Influx and Seeding , 2007, The Journal of Neuroscience.

[51]  M. Saarma,et al.  Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo , 2007, Nature.

[52]  S. Michnick,et al.  A highly sensitive protein-protein interaction assay based on Gaussia luciferase , 2006, Nature Methods.

[53]  Anne E Carpenter,et al.  CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.

[54]  R. Barbour,et al.  Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease* , 2006, Journal of Biological Chemistry.

[55]  Ivano Bertini,et al.  Protonless NMR experiments for sequence-specific assignment of backbone nuclei in unfolded proteins. , 2006, Journal of the American Chemical Society.

[56]  C. Dobson,et al.  Heat Shock Protein 70 Inhibits α-Synuclein Fibril Formation via Preferential Binding to Prefibrillar Species* , 2005, Journal of Biological Chemistry.

[57]  Takeshi Iwatsubo,et al.  Aggresomes Formed by α-Synuclein and Synphilin-1 Are Cytoprotective* , 2004, Journal of Biological Chemistry.

[58]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[59]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[60]  S. Vanhatalo,et al.  Neurturin is a neurotrophic factor for penile parasympathetic neurons in adult rat. , 2000, Journal of neurobiology.

[61]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[62]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[63]  W. Gibb,et al.  THE SIGNIFICANCE OF THE LEWY BODY IN THE DIAGNOSIS OF IDIOPATHIC PARKINSON'S DISEASE , 1989, Neuropathology and applied neurobiology.

[64]  S. Munro,et al.  A C-terminal signal prevents secretion of luminal ER proteins , 1987, Cell.